| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biolife Solutions, Inc. (BLFS) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. BLFS is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.96M | $131.30M | - | |
| CEO | 733.7K | $16.17M | - | |
| VP | 390.2K | $8.60M | - | |
| CFO | 216.1K | $4.76M | - | |
| Other | 163.8K | $3.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Aebersold Sarah61 | Chief Human Resources Officer | Sell | 862 | $16.76 | $14,447.12 | -2.0% | -7.6% | +52.2% | |
| Jan 19, 2024 | Berard Todd68 | Chief Marketing Officer | Sell | 1,232 | $16.76 | $20,648.32 | -1.1% | -7.6% | +52.2% | |
| Jan 2, 2024 | Berard Todd68 | Chief Marketing Officer | Sell | 491 | $16.75 | $8,224.25 | -0.4% | +12.0% | +63.8% | |
| Jan 2, 2024 | Foster Karen A.68 | Chief Quality And Operations | Sell | 601 | $16.75 | $10,066.75 | -0.5% | +12.0% | +63.8% | |
| Jan 2, 2024 | Mathew Aby J.69 | EVP &Chief Scientific Officer | Sell | 697 | $16.75 | $11,674.75 | -0.3% | +12.0% | +63.8% | |
| Dec 22, 2023 | Wichterman Troy61 | Chief Financial Officer | Sell | 314 | $16.79 | $5,272.06 | -0.5% | +13.9% | +70.9% | |
| Dec 1, 2023 | Aebersold Sarah61 | Chief Human Resources Officer | Sell | 394 | $12.37 | $4,873.78 | -0.9% | +27.5% | +107.3% | |
| Dec 1, 2023 | Berard Todd68 | Chief Marketing Officer | Sell | 394 | $12.37 | $4,873.78 | -0.3% | +27.5% | +107.3% | |
| Dec 1, 2023 | Wichterman Troy61 | Chief Financial Officer | Sell | 666 | $12.37 | $8,238.42 | -1.0% | +27.5% | +107.3% | |
| Dec 1, 2023 | Mathew Aby J.69 | EVP &Chief Scientific Officer | Sell | 591 | $12.37 | $7,310.67 | -0.2% | +27.5% | +107.3% |